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Effector T cells are critical for clearance of patho-
gens from sites of infection. Like cytotoxic CD8+
T cells, CD4+ helper T cells have been shown to
deliver effector molecules directionally toward the
immunological synapse, suggesting that infected
cells need to be engaged individually to receive
effector signals. In contrast, we show here that
CD4+ T cells stably contacted a minority of infected
cells, yet these interactions triggered intracellular
defense mechanisms in bystander cells in vivo. By
using a functional read-out, we provide evidence
that this effector bystander activity extends via
a gradient of IFN-g more than 80 mm beyond the
site of antigen presentation, promoting pathogen
clearance in the absence of immunological synapse
formation. Our results thus demonstrate that CD4+
T cells can exert their protective activity by engaging
a minority of infected cells.
INTRODUCTION
The adaptive immune response employs CD4+ helper and
CD8+ cytotoxic T cells, which recognize microbial antigens and
mediate pathogen clearance from sites of infection. Both T cell
types rely on effector mechanisms that enable them to perform
their tasks. CD8+ T cells induce target cell death by secretion
of lytic granules and engagement of proapoptotic receptors.
In contrast, CD4+ T cells produce cytokines and chemokines
that recruit and activate other cells of the immune system and
enable infected cells to upregulate genes involved in clearance
or containment of pathogens. CD4+ and CD8+ T cell effector
functions have to be tightly regulated in order to prevent misdir-
ected effector activities that would damage uninfected tissues
(Sancho et al., 2002).Several studies have established that CD8+ T cells are
remarkably accurate in killing their target cells specifically while
sparing neighboring cells. Pioneer experiments have shown that
in allophenic skin grafts as well as in tumor mosaics, only cells
that could be engaged by CD8+ T cells are eliminated, with no
apparent killing of bystander cells (Breart et al., 2008; Rosenberg
and Singer, 1988). Much less is known about how CD4+ T cells
deliver effector cytokines. Although cytokines can exert their
activity over long distances in vitro, it is unclear whether their
local concentration in vivo permits a range of action beyond
the cells directly contacted by CD4+ T cells. On the one hand,
it has been shown that cytokine-mediated STAT1 and STAT6
phosphorylation can be observed in T and B cells throughout
a reactive lymph node, suggesting widespread influence of
the cytokine milieu in secondary lymphoid organs (Perona-
Wright et al., 2010). On the other hand, delivery of cytokines
such as gamma-interferon (IFN-g) has been shown to be strictly
limited to the immunological synapse in vitro (Huse et al., 2006;
Kupfer et al., 1991; Poo et al., 1988). Also, static imaging of
effector CD4+ T cells in bacille calmette Gue´rin (BCG)-induced
granulomas has revealed that IFN-g is localized at the T cell-
antigen-presenting cell (APC) interface in vivo (Egen et al.,
2011), suggesting strictly localized effector activity at the site
of infection. However, even upon directional cytokine delivery,
it is unclear whether the action of IFN-g in infected tissues is
exerted solely on the APCs engaged by CD4+ T cells or whether
it extends to neighboring cells.
We addressed this question by using the mouse model of
cutaneous Leishmania major infection. L. major is an intracellular
parasite infecting phagocytes and causing cutaneous lesions.
It is well established that primary control of this pathogen
requires CD4+ T cells to deliver IFN-g to infected cells, resulting
in upregulation of inducible nitric oxide synthase (iNOS) and
parasite killing (Bogdan et al., 2000; Evans et al., 1993; Sacks
and Noben-Trauth, 2002).
Here, we have investigated whether CD4+ T cells have to
engage each L. major-infected cell individually for parasite clear-
ance, as would be expected if effector cytokines are delivered
with high local specificity. We found that although CD4+ T cellsImmunity 37, 147–157, July 27, 2012 ª2012 Elsevier Inc. 147
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Cells in the Dermis Is Stably Engaged by
CD4+ T Cells despite Widespread MHC
Class II Expression
(A) Intravital 2-photon imaging of T cell (green)
interactions with L. major (red)-infected cells in the
ear dermis. Rorc-creGFP lineage marker-positive
T cells (top) as well as adoptively transferred
ubiquitin-GFP expressing CD4+ T cells undergo
very few stable (longer than 30 min) interactions
with L. major-infected cells. Panels on the left
show T cell and parasite fluorescence as well as
the contact zone at one given time point during the
movie, the panels on the right represent time
projections of all time points over the duration of
60 min image acquisition. The time projection of
the interactions is represented as a heat map.
Scale bars represent 50 mm.
(B) Ear cells from L. major-infected C57BL/6 mice
were isolated and analyzed for DsRed content and
CD45, CD11b, and MHC class II expression. Cells
containing the DsRed-expressing parasite were
identified by plotting against green fluorescence
intensity (FL-1), which had been left unstained.
Cells from ears infected with nontransgenic para-
site served as controls to identify the DsRed+
population.
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Pathogen Control by CD4+ T Cell Bystander Activityformed a limited number of stable contacts with infected
cells, they nevertheless efficiently activated intracellular defense
mechanisms in infected cells by producing a gradient of effector
signals that extended more than 80 mm beyond the site of
T cell-APC interactions. As a result, pathogen control could be
achieved when as few as 10% of the infected cells were able
to present antigen to CD4+ T cells. Therefore, in contrast to cyto-
toxic CD8+ T cells, CD4+ T cells can extend their effector func-
tions beyond the immunological synapse and rely on bystander
effector activity to control intracellular pathogens.
RESULTS
A Minority of L. major-Infected Cells in the Dermis Is
Stably Engaged by CD4+ T Cells
In a previous study, we have analyzed interactions established
by adoptively transferred CD4+ T cells specific for the immuno-
dominant LACK antigen at the site of L. major infection by using
intravital 2-photon microscopy. These experiments reveal areas
of infected tissue being ignored by parasite-specific CD4+ T cells
(Filipe-Santos et al., 2009).We set out to test whether CD4+ T cell
contacts with L. major-infected cells are also limited in the
setting of an endogenous and polyclonal response, in a resistant
C57BL/6 genetic background. To this end, we employed Rorc-
cre 3 RosaGFP mice in which a large proportion of T cells
express GFP because of expression of RORgt in the thymus at
the double-positive stage (Sun et al., 2000) as well as a model
of adoptive transfer of GFP-expressing CD4+ T cells into148 Immunity 37, 147–157, July 27, 2012 ª2012 Elsevier Inc.Cd3e/ mice. Mice were infected intra-
dermally in the ear with 105 L. major
promastigotes expressing the fluorescent
protein DsRed, and intravital 2-photonimaging of the site of infection was performed 2 weeks later. In
line with our previous work, we could observe that prolonged
interactions between CD4+ T cells and infected phagocytes
were limited to a small number of hotspots (Figure 1A; Movies
S1 and S2 available online).
It has been suggested that L. major can modulate major
histocompatibility complex (MHC) class II expression in some
infected cells as a mechanism to evade the adaptive immune
response, and therefore differences in MHC class II surface
expression on infected cells might account for the heterogeneity
in T cell contacts (DeSouza Leao et al., 1995). In order to test this,
we isolated ear cells from C57BL/6 mice infected for 2 weeks
with DsRed-expressing L. major and determined MHC class II
expression on infected cells. More than 95% of the infected cells
were found to be CD45+CD11b+ and most exhibited a strong
surface expression ofMHCclass II protein (Figure 1B). Therefore,
other defects in antigen presentation might account for the
observation that, at a given time, immunological synapse forma-
tion by CD4+ T cells is restricted to a few infected phagocytes.
CD4+ T Cells Induce Intracellular Defense Mechanisms
in Bystander Cells
We envisioned two possible explanations for how resistant mice
could control L. major infection. As a first possibility, every in-
fected cell would have to be engaged by a CD4+ T cell. Despite
the low frequency of T cell-APC interactions at a given time, the
proportion of infected cells activated by T cell engagementwould
progressively increase over the several weeks known to be
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Figure 2. Antigen-Specific CD4+ T Cells
Induce iNOS and Mediate L. major Contain-
ment as Early as 2 Weeks Postinfection
(A) MHC class II is critical for iNOS induction and
parasite containment. Cells from L. major-infected
ears were isolated and analyzed for intracellular
iNOS (top) and L. major DsRed content (bottom).
Cells stained with a non-iNOS-specific polyclonal
goat primary IgG were used to define the iNOS+
population, and control cells from ears infected
with nontransgenic parasite served as controls to
identify the DsRed-positive cells.
(B) Antigen-specific CD4+ T cells are required to
induce iNOS and contain L. major.Cd3e/ female
mice were adoptively transferred with CD4+ T cells
from wild-type or Marilyn TCR females or left
untreated. Two days posttransfer, mice were in-
fected in the ear dermis and blood was taken to
determine the presence of circulating CD4+ T cells
(middle). After 2 weeks of infection, cells from
the infected ears were isolated and analyzed for
intracellular iNOS (right).
(C and D) The ratio of iNOS-expressing to iNOS-
negative infected cells is shown in (C); L. major
DsRed fluorescence in infected cells (normalized
to infected wild-type cells) is shown in (D). Each
dot represents an individual ear; horizontal lines
denote the median value of groups; **p < 0.01; ns,
not significant.
See also Figure S1.
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Pathogen Control by CD4+ T Cell Bystander Activityrequired for the control of the infection. Alternatively, CD4+ T cells
could exert their effector functions beyond directly engaged
cells. In this scenario, only a subset of infected cells would
need to be targets of stable contact formation with CD4+ T cells.
It is well known that MHC class II-mediated antigen presenta-
tion promotes upregulation of the inducible nitric oxide synthase
(iNOS), which is in turn critical for the containment and control of
L. major (Evans et al., 1993). We observed as early as 2 weeks
postinfection that in addition to an impaired iNOS expression,
infected cells of MHC class II-deficient mice exhibited an
increased parasite DsRed content as compared to wild-type
controls (Figure 2A). In order to show that the response in
wild-type mice is attributable to cognate antigen recognition
by CD4+ T cells, we adoptively transferred Cd3e/ mice with
CD4+ T cells isolated from either wild-type mice or from trans-
genic mice expressing a monoclonal T cell receptor (TCR) of
irrelevant specificity (Marilyn TCR) (Figure 2B). The transfer of
polyclonal wild-type but not of Marilyn TCR CD4+ T cells
was sufficient to restore iNOS expression in Cd3e/ recipients.
In addition, wild-type T cells allowed for a better containment of
the parasite asmeasured by the parasite fluorescence in infectedImmunity 37, 147–phagocytes (Figures 2C and 2D). T cell
adoptive transfers were also performed
into Rag2/Il2rg/ recipients that lack
T, B, and natural killer (NK) cells. In these
mice, iNOS induction was restored by
transfer of wild-type but not Ifng/
CD4+ T cells (Figure S1). Furthermore, to
test whether iNOS induction requires anti-
genic recognition by T cells at the site ofinfection, we transferred T helper 1 (Th1) cells bearing the OT-II
TCR specific for the OVA(323-339) peptide into Rag2/Il2rg/
mice. Injection of the cognate peptide at the site of infection
restored iNOS expression, highlighting the importance of local
antigen recognition by effector CD4+ T cells (Figure S1). Alto-
gether, these results confirm that at 2 weeks postinfection,
parasite-specific CD4+ T cells are critical for inducing defense
mechanisms and reducing parasite load in infected cells.
Although these results confirmed that MHC class II recogni-
tion is critical for induction of defense mechanisms in our
settings, it remained to be established whether all infected
cells needed to be engaged directly by CD4+ T cells for
the control of the infection. We addressed this question by
preparing mixed bone marrow (BM) chimeras consisting of
50% MHC class II-deficient (CD45.2+) BM and 50% congenic
wild-type (CD45.1+) BM. In these animals, we analyzed iNOS
induction and parasite content in infected wild-type and MHC
class II-deficient cells after 2 weeks of L. major infection. This
strategy enabled us to test whether iNOS could be induced
in a cell incapable of antigen presentation to the host CD4+
T cells. Cells isolated from infected wild-type and MHC class157, July 27, 2012 ª2012 Elsevier Inc. 149
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Figure 3. CD4+ T Cells Induce Intracellular Defense Mechanisms in Bystander Cells
(A) Lethally irradiated CD45.1 wild-typemice were reconstituted either with amixture of 50%wild-type CD45.1 and 50%CD45.2 BM cells of either wild-type (top)
orMHCclass II-deficient (middle) mice. Mice were infected in the ear dermis and after 2weeks of infection, cells from the infected ears were isolated and analyzed
for intracellular iNOS and L. major DsRed fluorescence in infected wild-type and congenically marked MHC class II-deficient cells. Cells from nonchimeric wild-
type and MHC class II-deficient mice infected individually and mixed only after infection served as controls (bottom).
(B) Overview of iNOS expression (left) and L. major DsRed fluorescence (right) in infected phagocytes (normalized to infected CD45.1+ wild-type cells of
BM chimeras containing 50% wild-type and 50% CD45.2 BM cells). Each dot represents an individual ear; horizontal lines denote the median value of groups;
*p < 0.05; ***p < 0.001; ns, not significant.
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Pathogen Control by CD4+ T Cell Bystander ActivityII-deficient mice that were mixed after isolation from the ears
served as controls (Figure 3A). As expected, when infected
separately, MHC class II-deficient cells showed poor expres-
sion of iNOS and displayed a higher DsRed parasite fluo-
rescence than cells from wild-type mice. In contrast, in BM
chimeras consisting of 50% MHC class II-deficient BM and
50% congenic wild-type BM, iNOS expression was completely
restored in MHC class II-deficient cells. As a consequence, the
presence of wild-type cells in chimeras resulted in a reduction
in parasite content within infected MHC class II-deficient cells
(Figures 3A and 3B). Thus, MHC class II-deficient cells are
perfectly able to induce intracellular defense mechanisms in
the presence of wild-type cells capable of antigen presentation150 Immunity 37, 147–157, July 27, 2012 ª2012 Elsevier Inc.to CD4+ T cells. When we infected the mixed BM chimeras for
shorter time periods, we observed that iNOS expression in wild-
type as well as MHC class II-deficient cells was increasing with
the same kinetics, indicating that the bystander activation is
achieved rapidly (Figure S2). Taken together, our data suggest
that CD4+ T cells exert their effector functions not only on cells
engaged in an immunological synapse but also on nonpresent-
ing bystander cells.
Control of L. major Infection through CD4+ T Cell
Bystander Effector Activity
Because we demonstrated that CD4+ T cells could induce
iNOS in cells incapable of MHC class II-dependent antigen
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Figure 4. Bystander CD4+ Effector Activity
Contributes to Control of L. major Infection
(A) Lethally irradiated CD45.1 wild-type mice
were reconstituted either with a mixture of 50%
wild-type CD45.1 and 50% CD45.2 MHC class
II-deficient BM (red open symbols), 100% wild-
type BM (black closed symbols), or 100% MHC
class II-deficient BM (red closed symbols). Mice
were infected in the ear dermis and the pathology
in terms of swelling was monitored weekly. Ear
swelling is expressed as relative value normalized
to the maximal swelling of each group, symbols
denote the average value of at least four ears, error
bars denote the SEM.
(B and C) After 15 weeks of infection, cells from the
ears and cervical lymph nodes were isolated and
analyzed for L. major infection in terms of DsRed
fluorescence. Each dot in (C) represents an indi-
vidual ear; horizontal lines denote the median
value of groups; *p < 0.05; **p < 0.01; ***p < 0.001;
ns, not significant.
(D) Limiting dilution cultures of representative
ear cell preparations were performed to confirm
parasite load values from flow cytometry. Bars
represent the average of at least three ears, error
bars denote the SEM.
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Pathogen Control by CD4+ T Cell Bystander Activitypresentation, we asked whether such bystander effector activity
could be sufficient to resolve L. major infection. Thus, we
performed long-term ear infections with bone marrow chimeras
reconstituted with either 100% wild-type, 100% MHC class
II-deficient, or 50% wild-type and 50% MHC class II-deficient
mixed BM. We followed ear swelling over 15 weeks and deter-
mined parasite load at the end of the experiment. In line with
reported data, the ear swelling in mice reconstituted with
100% wild-type but not with 100% MHC class II-deficient BM
resolved by 10–12 weeks (Erb et al., 1996). Strikingly, kinetics
and severity of ear pathology in animals with a mixture of wild-
type and MHC class II-deficient BM was identical to controls
reconstituted with wild-type BM only (Figure 4A). In addition,
no parasite fluorescence could be detected in cells from ear
and draining lymph nodes of these animals. In contrast, mice re-
constituted with only MHC class II-deficient BM exhibited heavy
parasite burden in both tissues (Figures 4B and 4C). In order to
exclude loss of DsRed fluorescence expression as an explana-
tion for the loss of parasite signal, we confirmed our results
obtained by flow cytometry by using limiting dilution parasite
cultures of the infected ear (Figure 4D). Taken together, these
data establish that bystander CD4+ T cell effector activity isImmunity 37, 147–an efficient mechanism to mediate clear-
ance of L. major from the site of infection.
IFN-g Is a Soluble Mediator of
Bystander CD4+ T Cell Effector
Activity
Our results strongly suggest that CD4+
T cells exert their function on bystander
cells via a soluble mediator. IFN-g is
required for iNOS induction in L. major-
infected phagocytes and is produced byT cells to control the infection in resistant mouse strains (Bogdan
et al., 2000; Evans et al., 1993; Wakil et al., 1998). Although it has
been shown to be secreted directly into the immune synapse by
effector CD4+ T cells, it remained possible that IFN-g reached
neighboring cells at a sufficiently high concentration to cause
the bystander effect. This would imply that the bystander effect
is lost in cells that cannot sense IFN-g. Therefore, we tested
this possibility by generating mixed BM chimeras reconstituted
with 50% IFN-gReceptor 1/ (Ifngr1/) BM and 50%congenic
wild-type BM and analyzed whether iNOS expression in
Ifngr1/ cells could be rescued by wild-type cells (Figure 5A).
Strikingly, 2 weeks after L. major infection, iNOS expression
remained completely absent in Ifngr1/ cells of these mixed
BM chimeras (Figures 5A and 5B), indicating that in contrast to
MHC class II-dependent immune synapse formation, IFN-g
receptor signaling is required in every individual cell in order to
induce iNOS expression.
Next, we sought to create a situation in which iNOS could only
be induced as a result of a bystander T cell effector activity. To
this end, we generated mixed BM chimeras consisting of 50%
Ifngr1/ BM and 50% MHC class II-deficient BM in which the
only cells capable of responding to IFN-g were incompetent for157, July 27, 2012 ª2012 Elsevier Inc. 151
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Figure 5. IFN-g Is a Soluble Mediator of
Bystander CD4+ T Cell Effector Activity
(A and B) Lethally irradiated CD45.1wild-typemice
were reconstituted either with a mixture of 50%
wild-type CD45.1 and 50% CD45.2 BM cells of
either Ifngr1/ (A and B) or wild-type (B) mice.
Mice were infected in the ear dermis and after
2 weeks of infection, cells from the infected ears
were isolated and analyzed for intracellular iNOS
in infected wild-type and congenically marked
Ifngr1/ phagocytes. Each dot in (B) represents
an individual ear; horizontal lines denote the
median value of groups; ***p < 0.001; ns, not
significant.
(C) In order to completely disconnect events of
antigen presentation and iNOS induction by IFN-g,
lethally irradiated Ifngr1/ mice were recon-
stituted either with a mixture of 50% Ifngr1/ and
50% BM cells of either wild-type or MHC class
II-deficient mice. Mice were infected in the ear
dermis and after 2 weeks of infection, cells from
the infected ears were isolated and analyzed for
intracellular iNOS in infected MHC class II-ex-
pressing (Ifngr1/) and nonexpressing (Ifngr1+/+)
phagocytes.
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Pathogen Control by CD4+ T Cell Bystander Activityantigen presentation. Upon infection of these mice, only the
MHC class II-negative cells produced iNOS (Figure 5C), indi-
cating that events of antigen presentation and iNOS induction
by IFN-g can be completely disconnected.
Taken together, these results strongly suggest that IFN-g
is a soluble mediator responsible for the observed bystander
CD4+ T cell effector activity.
A Cytokine Gradient Is Responsible for iNOS Induction
around Sites of Antigen Presentation
Our results obtained in chimeras containing equivalent numbers
of wild-type andMHC class II-deficient cells indicated that CD4+
T cells do not need to interact with every infected cells to control
the infection. To estimate the proportion of antigen-presenting
cells required for normal iNOS induction, we titrated the minimal
amount of wild-type cells necessary to induce iNOS in MHC
class II-deficient cells in mixed BM chimeras. We observed
that as few as 10% of wild-type BM mixed with MHC class
II-deficient BM was sufficient to rescue iNOS production (Fig-
ure 6A). In chimeras with less than 10% wild-type cell content,
we observed that even wild-type phagocytes were no longer
able to induce iNOS (Figure 6B). We speculate that in this situa-
tion, the amount of antigen-presenting cells required to prime
T cell responses in the draining lymph node becomes limiting.
Therefore, it is possible that bystander iNOS induction could
be achieved at the site of infection in the presence of less than
10% wild-type APCs, provided that a sufficient T cell response
was elicited during the priming phase. At any rate, our results
suggest that bystander CD4+ T cell effector activity can be
induced efficiently by a small fraction of APCs.152 Immunity 37, 147–157, July 27, 2012 ª2012 Elsevier Inc.Our results raised the question of how
far bystander CD4+ T effector cell activity
extends beyond sites of antigen presen-
tation. To address this issue, we deviseda strategy to visualize the bystander effect in situ. We generated
BM chimeras with 90% MHC class II-deficient BM and 10%
Rag2/ GFP BM, yielding animals in which only a small fraction
of cells are capable of MHC class II-mediated antigen presenta-
tion. In addition, these APCs could be identified by their GFP
expression. When these mice were infected with L. major, we
observed sparse GFP-positive cells throughout the dermis (Fig-
ure 7A). Confirming our previouswork (Filipe-Santos et al., 2009),
infected cells were found to be completely immotile at this time
point (Movie S3). We therefore analyzed the range of T cell
effector activity by staining of tissue sections. Strikingly, we
found that iNOS expression was not limited to GFP+ MHC class
II-expressing cells, but extended well beyond the site of antigen
presentation, highlighting the finding of bystander CD4+ T cell
activity on nonpresenting cells (Figure 7A, additional examples
shown in Figure S3).
In order to determine the range of iNOS induction in bystander
cells, we devised an automated approach to measure the iNOS
staining intensity in infected cells in correlation with distance to
parasitized cells capable of presenting antigen (Figure 7B). We
observed that the iNOS content in L. major-containing areas
was highest within or very close to (up to 20 mm) GFP-expressing
(thus MHC class II-sufficient) infected cells. Interestingly, iNOS
staining intensity remained elevated even as far as 80 mm from
GFP-expressing cells but decreased gradually with the distance
from the closest MHC class II-expressing infected APC (Fig-
ure 7C). Control experiments were done with BM chimeras
with 90%wild-type BM as the nonfluorescent cell compartment.
In these mice, in which GFP+ cells are no longer the only sites of
antigen presentation, we observed, as expected, an absence of
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See also Figure S2.
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(Figure S3). Overall, our data support the idea that IFN-g
produced by CD4+ T cells diffuses from the site of antigen
presentation and reaches sufficient concentration to induce
iNOS in cells located more than 80 mm away. Such a mechanism
allows for CD4+ T cell control of an intracellular pathogen by
engagement of a minority of infected cells.
DISCUSSION
In the present study, we have uncovered the microanatomy
of CD4+ T cell effector activity at the site of L. major infection.
We have shown that engagement of a very small number of
L. major-infected cells by CD4+ T cells is sufficient to trigger
widespread induction of intracellular defense mechanisms
throughout the parasitized tissue. Also, we established that
delivery of CD4+ T cell effector functions takes its effect through
a long-range gradient originating from the site of antigen presen-
tation. Thus, in contrast to cytotoxic T cells, helper T lympho-
cytes can largely rely on bystander effector activity to control
intracellular infections.
The delivery of effector functions by CD4+ or CD8+ T cells has
been shown to be initiated upon formation of an immunological
synapse with APCs. As for CD8+ T cell-mediated killing, several
studies support the idea that the delivery of cytotoxic granules
uniquely affect the engaged target cells with no detectable
bystander activity (Breart et al., 2008; Rosenberg and Singer,
1988). Addressing the same question for cytokine delivery by
CD4+ T cells is complicated by the lack of means to readily iden-
tify cells receiving cytokine signals. The finding that effector
cytokines, such as IFN-g, are delivered in a directional mannerby CD4+ T cells has supported the idea that cytokine activity is
spatially confined and may target only cells that are directly
engaged. Such a highly directional mode of cytokine delivery
implies that, for controlling an intracellular pathogen, effector
CD4+ T cells would have to interact directly with most if not all
infected cells.
On the other hand, several observations have raised the
possibility that infections could be controlled by CD4+ T cells
even when some infected cells fail to form an immunological
synapse. In an experimental system in which MHC class II
expression is restricted to CD11c+ cells, L. major infection is still
resolved (Lemos et al., 2004). However, because CD11c+ cells
are the primary cell type infected in this model and because
this study did not identify infected cells, it was not clear whether
a substantial proportion of infected cells lacked the potential to
be recognized by CD4+ T cells (De Trez et al., 2009). A second
intriguing observation comes from two-photon intravital micros-
copy of T cell effector function during infections. Our data, in line
with previous studies imaging sites of L. major, Mycobacterium
bovis, or Toxoplasma gondii infection, revealed very limited
number of stable T cell interactions with infected cells (Chtanova
et al., 2009; Egen et al., 2011; Filipe-Santos et al., 2009).
Because these experiments are limited to a few hours of obser-
vations, it could not be assessedwhethermost infected cells end
up being contacted by T cells at least once during the effector
phase.
We have now demonstrated that CD4+ T cells need to engage
as few as 10% of all infected cells in order to trigger an efficient
response. With a series of mixed bone-marrow chimeras, we
have established that this response relies on a bystander
CD4+ T cell effector activity. Although several cytokines mightImmunity 37, 147–157, July 27, 2012 ª2012 Elsevier Inc. 153
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Pathogen Control by CD4+ T Cell Bystander Activitycontribute to such bystander activity, we showed a cardinal role
for IFN-g because IFN-gR signaling and antigen presentation
were spatially separable. To quantify how far IFN-g secreted
from CD4+ T cells may act in vivo, we developed a strategy to
visualize the activation of intracellular defense mechanisms in
cells located around isolated antigen-presenting cells. We could
show that iNOS expression was strongest in the vicinity of sites
of antigen presentation and slowly declined with the distance to
these spots. Such a gradient-like mode of activation allowed for
iNOS induction in cells situated more than 80 mm away. There-
fore, our data strongly suggest that IFN-g produced at sites of
antigen presentation reaches concentrations sufficient to acti-
vate iNOS over such long distances. Cytokine secretion could
occur either toward the immunological synapse or multidirec-
tionally around the effector T cell. However, IFN-g has been
shown to belong to the group of cytokines secreted directionally
toward the APC (Huse et al., 2006). Our data show that IFN-g
activity extends beyond the T cell-APC interface, so we propose
that the cytokine diffuses substantially from the immunological
synapse. We cannot formally exclude that IFN-g is secreted by
T cells after they have disengaged from the APC, thus distrib-
uting IFN-g to the surrounding space. However, the gradual
decrease in iNOS induction away from site of antigen presenta-
tion argues against this possibility. Also, the observation of
a gradient initiated from MHC class II-positive cells suggests
only little contributions in our system for other IFN-g-producing
cells, such as NK or CD8+ T cells. Noteworthy, NK cells play
a more important role during the very first days of infection and
it will be interesting to investigate whether NK cells and CD8+
T cells use the same mode of IFN-g delivery (Barcia et al.,
2008; Diefenbach et al., 1999; Scharton and Scott, 1993). In
this respect, areas of iNOS induction colocalizing with the pres-
ence of IFN-g-producing NK cells have been observed in the
spleen at early time points of Listeria infection (Kang et al.,
2008). Although our study focuses on the delivery of IFN-g, it
will be interesting to compare the range of action of other cyto-
kines in vivo, including those that are not delivered toward the
immunological synapse.
Interestingly, we observed a substantial number of nonin-
fected cells producing iNOS in the dermis. Although we cannot
exclude that some of these cells represent phagocytes that had
been previously infected and cleared L. major, this observation
raises the possibility that the bystander effect we describe also
pertains to noninfected phagocytes. As a consequence, IFN-g
might even prepare uninfected cells for parasite invasion by up-
regulating intracellular defense mechanisms prior to uptake of
the parasite. Hence, such a bystander effect on uninfected cells
is also likely to reduce the parasite’s ability to spread to neigh-
boring cells. Whether resolution of L. major infection mostly
relies on parasite killing in already infected cells or on prevention
of parasite dissemination will be interesting to address in future
studies.L. major-infected zones were identified automatically according to mean DsRed fl
less than four infected zones around themselves) were excluded.
(C) Infected zones were grouped according to distance to the nearest infected G
Each dot represents an individual zone; horizontal lines denote the average; *p <
See also Figure S3.Pathogens have developed a variety of mechanisms to evade
the host’s immune response (Bedoui et al., 2010; Zambrano-
Villa et al., 2002). For example, Leishmania spp. have been
shown to downregulate antigen presentation and costimulatory
molecules in infected macrophages (De Souza Leao et al.,
1995; Muraille et al., 2010; Rub et al., 2009). With a large pop-
ulation of parasitized cells not presenting antigen to CD4+
effector T cells, it would be detrimental for the host if the induc-
tion of defensive mechanisms would rely completely on direct
engagement of infected cells by T cells in an immunological
synapse. Thus, CD4+ effector bystander activity might repre-
sent a means of reaching cells that are not able to present
antigen. Bystander CD4+ T cell effector activity could therefore
act complementary to the highly directional delivery of CTL
effector functions and represent an important mechanism for
the adaptive immune system to keep in check localized infec-
tions by intracellular pathogens.
EXPERIMENTAL PROCEDURES
Mice and Parasites
Wild-type C57BL/6 and CD45.1 (B6.SJL-PtprcaPepcb/BoyJ) mice were
purchased from Charles River laboratories (Wilmington, MA), MHC class II-
deficient (B6.129S2-H2dlAb1-Ea) (Madsen et al., 1999), Ifngr1 / (B6.129S7-
Ifngr1tm1Agt) (Huang et al., 1993), Cd3e/ (B6-Cd3etm1Mal) (Malissen et al.,
1995), Marilyn TCR (transgenic for the H-Y male antigen and deficient in
Rag2, B6.129-Rag2tm1FwaTg(TcraHya,TcrbHya)1Pas/Pas) (Lantz et al., 2000),
ubiquitin-GFP (C57BL/6-Tg(UBC-GFP)30Scha) (Schaefer et al., 2001), ubiqui-
tin-GFP crossed into Rag2/ (B6.129-Rag2tm1Fwa) (Shinkai et al., 1992), mice
transgenic for TCR specific for the OT-II antigen (B6.Cg-Tg(TcraTcrb)425Cbn)
(Barnden et al., 1998), Rag2/Il2rg/ (B6;129S4-Rag2tm1.1FlvIl2rgtm1.1Flv)
(Huntington et al., 2009), and Ifng/ (B6.129S7-Ifngtm1Ts) (Dalton et al.,
1993) mice were bred under specific-pathogen-free conditions at Institut Pas-
teur. Rorc-creGFP mice were obtained by crossing transgenic mice express-
ing Cre recombinase under control of the Rorc(gt) gene (Tg(Rorc(gt)-cre)
(Eberl and Littman, 2004) with ROSA26-EGFP (B6;129-Gt(ROSA)26Sortm2Sho)
(Mao et al., 2001) reporter mice. Animal experiments were performed in
accordance to the guidelines of Institut Pasteur for animal care and use.
For generating bone marrow chimeras, recipients were g-irradiated twice
within 3 hr with 550 rad and reconstituted with 33 107 donor BM cells intrave-
nously. For titration of the fraction of MHC class II-sufficient cells necessary to
induce bystander CD4+ T cell effector activity, CD45.2 wild-type mice were
reconstituted with mixtures of MHC class II-deficient BM containing 0%,
5%, 10%, 20%, 30%, or 40% of CD45.1 wild-type bone marrow. Actual
reconstitution efficiency was determined by flow cytometry analysis of
CD45.1, CD45.2, and MHC class II staining of cells isolated from the infected
ear. Mice with residual CD45.2 wild-type cells (i.e., more CD45.2 cells than
CD45.1 MHC class II-positive cells in animals with less than 5% CD45.1
phagocytes) were excluded from the analysis.
L. major LRC-L137 V121 wild-type or DsRed-expressing parasite (Misslitz
et al., 2000; So¨rensen et al., 2003) was grown for maximally five passages in
M119 medium supplemented with 10% heat-inactivated fetal bovine serum,
0.1 mM adenine, 1 mg/ml biotin, 5 mg/ml hemin, and 2 mg/ml biopterin (all
from Sigma). For infection, 105 stationary phase promastigotes were resus-
pended in PBS and injected into the ear dermis. For long-term infections,
ear thickness was determined weekly. Where indicated, serial dilutions of
ear cells (see below) were prepared in parasite medium.uorescence intensity, and zones at the border of the infected regions (i.e., with
FP-expressing cell and iNOS staining intensity of each zone was determined.
0.05; **p < 0.01; ***p < 0.001; ns, not significant.
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CD4+ T cells for adoptive transfer were purified from axillary, brachial, cervical,
and inguinal lymph nodes as well as from the spleen by negative selection with
the CD4 isolation kit and MACS purification (Miltenyi Biotech, Bergisch Glad-
bach, Germany) according to the manufacturer’s instructions. 1–2 3 107
T cells per recipient were injected intravenously. The presence of transferred
T cells in peripheral blood was verified 2 days posttransfer by flow cytometry.
At 3–4 days posttransfer, mice were infected as described.
Intravital Imaging
Mice were anesthetized and prepared for intravital microscopy as described
previously (Filipe-Santos et al., 2009). A coverslip sealed to a surrounding par-
afilm blanket was placed onto the ear and covered with deionized water to
immerge a 203/0.95 NA dipping objective (Olympus). Two-photon imaging
was performed with a DM6000 upright microscope equipped with a SP5
confocal head (Leica Microsystems, Wetzlar, Germany) and a Chamaeleon
Ultra Ti:Sapphire laser (Coherent, Santa Clara, CA) tuned at 920 nm. Emitted
fluorescence was passed to nondescanned detectors through dichroic
mirrors. Typically, images from 10–15 z planes spaced 2 mm were collected
every 1–2 min for up to 2 hr.
Flow Cytometry
Ears were separated into dorsal and ventral sheets by jagged forceps
and digested in RPMI 1640 medium containing 1 mg/ml Collagenase and
50 ng/ml DNase (Sigma-Aldrich) for 45 min at 37C and then passed through
a 70 mm cell strainer. Cell suspensions were fixed for 1 hr at 4C with a 2%
methanol-free formaldehyde solution (Polysciences, Warrington, PA) in phos-
phate-buffered saline. For iNOS staining, cells were permeabilized with Perm/
Wash solution (BD Biosciences) according to the manufacturer’s instructions
and stained with goat anti-NOS2 polyclonal IgG (Santa Cruz Biotechnology,
Santa Cruz, CA) and DyLight-649 conjugated anti-goat secondary antibody
(Jackson ImmunoResearch, West Grove, PA). Surface staining of cells was
performed with APC-eFluor780 conjugated anti-CD45.2 (clone 104), APC-
eFluor780 or PerCP-Cy5.5 conjugated anti-CD11b (clone M1/70), eFluor450
conjugated anti-I-A and I-E (clone M5/114.15.2), APC conjugated anti-CD4
(clone RM4-5), eFluor450 or APC-eFluor780 conjugated anti-CD3ε (clone
17A2), FITC conjugated anti-CD45.1 (clone A20) (all from eBioscience), Pacific
Blue conjugated anti-CD45.2 (clone 104) antibody (BioLegend), or APC-Cy7
conjugated anti-CD45 (clone 30F11) antibody (BD Biosciences). All cell prep-
arations were Fc-blocked by CD16/32 antibody (eBiosciences) prior to staining
and analyzed on a FACSCanto cytometer (BD Biosciences). Data were
analyzed with the FlowJo software (TreeStar, Ashland, OR).
Immunofluorescence Microscopy
Ears were incubated in a 4%methanol-free formaldehyde solution (Polyscien-
ces) in phosphate-buffered saline for 2 hr at 4C, then equilibrated overnight
with phosphate-buffered saline containing 20% sucrose at 4C and snap-
frozen in OCT compound (Sakura Finetek, Torrance, CA) by liquid nitrogen.
20 mmcryosectionswere air-dried, permeabilized for 10min at 20Cwith phos-
phate-buffered saline containing 0.1% Triton X-100 (Sigma-Aldrich), blocked
for 1 hr with phosphate-buffered saline containing 10% bovine serum, stained
with rabbit anti-NOS2 polyclonal IgG (Santa Cruz Biotechnology) and DyLight-
649 conjugated anti-rabbit secondary antibody (Jackson ImmunoResearch),
and mounted with ProLong Gold antifade reagent (Invitrogen). The stained
tissue sections were analyzed with a DM6000 upright microscope equipped
with a SP5 confocal head (Leica Microsystems). GFP, DsRed, and DyLight-
649 were excited with an argon laser at 488 nm and He/Ne lasers at 543 nm
and 633 nm, respectively. Typically, confocal stacks of 10–15 mm thickness
and 1 mm z spacing were acquired with a 403/0.8 NA water immersion
objective.
Image Processing and Analysis
Intravital three-dimensional time series were processed and superimposed
with the Imaris software (Bitplane, Zu¨rich, Switzerland). Interaction of T cells
with L. major-infected phagocytes was analyzed with the colocalization plugin
of ImageJ (NIH, http://rsb.info.nih.gov/ij/). For analysis of iNOS expression in
histological sections, colocalization of GFP and DsRed was first determined
in confocal stacks to identify L. major-infected GFP-expressing cells. The156 Immunity 37, 147–157, July 27, 2012 ª2012 Elsevier Inc.images were then projected to two dimensions and segregated into 10 3
10 mm zones for measurements of iNOS fluorescence in dependence of the
distance from the nearest zone in which GFP and DsRed were colocalized.
Statistical Analysis
Statistical analyses comparing groups of infected mice were performed with
the Mann-Whitney U test of the Prism 5 software. Statistical significance of
differences in iNOS staining intensities in dependence of distance to infected
MHC class II-expressing cells was analyzed by a one-way ANOVA followed by
a Tukey column pair comparison post-test in the Prism 5 software. A p value of
less than 0.05 was considered as significant and marked with an asterisk
in figures. Values of less than 0.01 or 0.001 were assigned two and three
asterisks, respectively.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
three figures, and three movies and can be found with this article online at
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